By / November 20, 2020

The EU High Court is clear “CBD is not a drug”

The European Union High Court has just made public its ruling on the question of CBD, and their decision has consumers and businesses over the world celebrating. CBD extracted from all parts of the hemp plant is legal.

According to the European Union’s High Court, cannabidiol (CBD) present in hemp “has no psychotropic effects or harmful effects on human health” and furthermore “CBD does not appear to have any… harmful effect on human health,” the judges wrote, outlining the grounds on which they decided the case.

The European High Court of Justice has just ruled that CBD is not a narcotic. This decision by the European Union’s highest court (ECJ) is a setback for European nations like France, which are trying to crack down on CBD products on the grounds that they are harmful to the health of citizens.

In order to learn more about the recent rulings by EU courts on cannabis, or to stay in touch with the wider world of international hemp news, download our companion Hemp.IM app.

French justice against European justice

The case that came before the EU High Court came out of France. The French justice system against a company in the Czech Republic that sold Cannabidiol extracted from the entire hemp plant, which was subsequently used in electronic cigarette cartridges. The French courts argue that they only allow the extraction of the leaves and stems, not the whole plant.

The European Court of Justice (ECJ) ruled on Thursday that it is illegal to ban the marketing of cannabidiol (CBD) in France, regardless of what part of the plant it was extracted from. It stresses that this molecule present in the hemp plant, or cannabis sativa, “does not have any psychotropic effect or harm to human health”.

This ECJ ruling refers to cannabidiol “legally produced in another EU Member State when it is extracted from the whole of the cannabis sativa plant”. This ruling will deprive many cases and complaints in France of a legal basis.

French Court loses in its interpretation to the European High Court

European justice was called on by the Court of Appeal of Aix-en-Provence. The Court of Appeal was due to rule in October 2018 on the fate of two pioneers of CBD use in electronic cigarettes. The Court of Appeal was concerned that the French regulations could be incompatible with those of the EU.

The Marseille businessmen, Sébastien Béguerie and Antonin Cohen-Adad, were sentenced in the first instance by the Marseille Criminal Court to 18 and 15 months conditional imprisonment and a fine of 10,000 euros. They were charged with using oil with CBD legally produced in the Czech Republic and extracted from the entire hemp plant with its leaves and flowers. France previously only allowed the use of seeds and fibres for this purpose.

“It’s a big step” said Antonin Cohen-Adad with Sébastien Béguerie, “Until now, we had no right to extract hemp and regulatory vagueness reigned. Here, Europe clarified the rule. This verdict is an important step in ensuring the safety of consumers of CBD products,” he continued, relieved.

Reaction of lawyers defending the position now approved by the European High Court

“We have just learned of the publication of the decision of the European Court of Justice in the so-called Kanavape case. It is a resounding victory for the industry” said a spokesperson for L630, a group of lawyers and jurists who defend many CBD stores.

“This decision is a slap in the face for France. For two years we were led to believe that the legislation should be applied restrictively. Hundreds of shops have been closed, dozens of young entrepreneurs imprisoned. We are moved because today, the European Court of Justice confirms our reading of the law “, says Bechir Saket, vice-president of L630,

In its ruling the ECJ invokes “the free movement of goods” in the EU which “is opposed to national regulations” such as that of France, “given that the CBD in question […] cannot be regarded as a narcotic “. In June of this year the High Court has already ruled that the product from another country of the Union cannot be banned.

“The legal reading of the ECJ is even more favourable than we imagine,” says Béchir Saket. “We have worked hard to assert a coherent vision of legislation, the European Court of Justice agrees with us.”

Call on Mildeca to amend legislation

The burden of action now falls on Mildeca, the inter-ministerial organization that must react to the ruling. It must amend the relevant legislation without delay. A commitment from their representatives, which they must now honor.

(Featured image by GregMontani via Pixabay)


This article was written by a third party contributor and does not reflect the opinion of, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in La Marihuana, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.

Comments are closed for this post.